CPA4 and endometrial cancer: Analyzing CPA4 mRNA expressions from TCGA and GEO databases and further validating the results with 116 clinical samples, He et al. reported that CPA4 is significantly upregulated in endometrial cancer, which is correlated with tumor progression and poor prognosis [40].